Disease-Specific Survival by Treatment Modality in Patients with Stage IE Primary Thyroid Lymphoma: Discussion of Risks and Benefits
Crossref DOI link: https://doi.org/10.1245/s10434-023-14762-z
Published Online: 2023-12-15
Published Print: 2024-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nilubol, Naris
Text and Data Mining valid from 2023-12-15
Version of Record valid from 2023-12-15
Article History
Received: 21 November 2023
Accepted: 25 November 2023
First Online: 15 December 2023
Free to read: This content has been made available to all.